Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
about
GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis.Recent advancements in esophageal cancer treatment in Japan.
P2860
Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phase II trial of biweekly doc ...... hageal squamous cell carcinoma
@en
type
label
Phase II trial of biweekly doc ...... hageal squamous cell carcinoma
@en
prefLabel
Phase II trial of biweekly doc ...... hageal squamous cell carcinoma
@en
P2093
P2860
P1476
Phase II trial of biweekly doc ...... hageal squamous cell carcinoma
@en
P2093
Atsuko Yamada
Kazuhiro Yoshida
Kazuya Yamaguchi
Naoki Okumura
Nobuhisa Matsuhashi
Tatsuhiko Miyazaki
Toshiyuki Tanahashi
Yoshihiro Tanaka
P2860
P2888
P304
P356
10.1007/S00280-016-2985-Y
P577
2016-02-20T00:00:00Z